News

Following a 4.2% decline over last year, recent gains may please Teva Pharmaceutical Industries Limited (NYSE:TEVA) institutional owners
NYSE:TEVA 1 Year Share Price vs Fair Value Explore Teva Pharmaceutical Industries's Fair Values from the Community ...
FDA Approves Ajovy for Migraine Prevention in Children and Teens
By Lori Solomon HealthDay ReporterMONDAY, Aug. 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
AstraZeneca: Great Portfolio, But Not A Great Price
AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...
Globes15h
Mon: TASE lower on profit taking
On the foreign exchange market, the representative shekel-dollar rate was set 0.495% lower than Monday, at NIS 3.418/$, and the representative shekel-euro rate was set 0.817% lower, at NIS 3.972/€.
TMCnet12h
SLP BREAKING NEWS: Simulations Plus, Inc. Stock Significantly Declines After Impairment Charge and Auditor Departure -- Investors Urged to Contact BFA Law
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the federal securities laws.
The Munich Eye1h
FDA Greenlights Ajovy for Migraine Prevention in Young Patients
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.